Chronic antibody-mediated rejection,
Showing 51 - 75 of >10,000
Blood Disease, Platelet Refractoriness, Antibody-mediated Rejection Trial in Guangzhou (same type infusion of main HPA antigen)
Completed
- Blood Disease
- +2 more
- same type infusion of main HPA antigen
-
Guangzhou, Guangdong, ChinaGuangzhou First People's Hospital
Aug 5, 2021
Renal Transplant Trial in Seoul (Rituximab, intravenous immune globulin)
Completed
- Renal Transplant
- Rituximab
- intravenous immune globulin
-
Seoul, Korea, Republic of
- +1 more
Oct 25, 2022
Torquetenovirus Load in Chinese Renal Transplant Recipients
Not yet recruiting
- Kidney Transplant Rejection
- +3 more
-
Hangzhou, China
- +3 more
Feb 5, 2023
Pediatric Heart Transplantation, Immunosuppression, Chronic Kidney Diseases Trial in United States (Everolimus, Tacrolimus,
Active, not recruiting
- Pediatric Heart Transplantation
- +6 more
- Everolimus
- +2 more
-
Birmingham, Alabama
- +24 more
Sep 2, 2021
Lung Transplant; Complications Trial in Nashville (Tacrolimus Extended Release Oral Tablet [Envarsus], Tacrolimus, Mycophenolate
Not yet recruiting
- Lung Transplant; Complications
- Tacrolimus Extended Release Oral Tablet [Envarsus]
- +4 more
-
Nashville, TennesseeVanderbilt University Medical Center
Jun 6, 2022
Kidney Transplant, BK Viremia Trial (Intravenous immunoglobulin)
Not yet recruiting
- BK Viremia
- +2 more
- Immunosuppression reduction/modification + intravenous immunoglobulin
- Immunosuppression reduction/modification
- (no location specified)
Oct 16, 2022
Chronic Kidney Failure Trial in Nantes (Belatacept 250 Milligram Intravenous Powder for Solution)
Not yet recruiting
- Chronic Kidney Failure
- Belatacept 250 Milligram Intravenous Powder for Solution
-
Nantes, Loire Atlantique, FranceCHU Nantes
Sep 28, 2022
Lung Transplant, ABO Incompatibility Trial in Toronto (Blood group A2 donor to blood group O recipient lung transplant surgery)
Recruiting
- Lung Transplant
- ABO Incompatibility
- Blood group A2 donor to blood group O recipient lung transplant surgery
-
Toronto, Ontario, CanadaToronto General Hospital, University Health Network
Dec 8, 2022
Kidney Transplant Rejection, Positive FCXM (T or B Cell Positive), Positive CDC Cross-Match (B Cell Positive) Trial in Chicago
Recruiting
- Kidney Transplant Rejection
- +3 more
- Spleen Transplantation/Removal
-
Chicago, IllinoisUniversity of Illinois at Chicago
Mar 30, 2021
Trifecta-Lung cfDNA-MMDx Study
Recruiting
- Lung Transplantation
-
Melbourne, Australia
- +5 more
Apr 18, 2023
Eliminating Need for Pancreas Biopsy Using Peripheral Blood
Recruiting
- Transplant;Failure,Kidney
- +3 more
- dd-cfDNA Blood Test
-
Washington, District of Columbia
- +2 more
Feb 23, 2022
Renal Transplantation Trial in Montpellier (Biological sample)
Unknown status
- Renal Transplantation
- Biological sample
-
Montpellier, FranceUhmontpellier
Jan 7, 2020
Longitudinal Study of Cell Free DNA in Lung Transplant
Completed
- Lung Transplant Rejection
-
Aurora, ColoradoUniversity of Colorado, Denver
Oct 31, 2022
Renal Transplant Rejection, Induction Therapy Trial (Rabbit Anti thymocyte globulin (rATG), Basiliximab)
Not yet recruiting
- Renal Transplant Rejection
- Induction Therapy
- Rabbit Anti thymocyte globulin (rATG)
- Basiliximab
- (no location specified)
Sep 22, 2022
Genome Transplant Dynamics
Recruiting
- Thoracic Organ Transplantation
-
Baltimore, Maryland
- +2 more
Jul 21, 2022
Kidney Transplant Rejection Trial in Barcelona (Extracorporeal Photopheresis)
Not yet recruiting
- Kidney Transplant Rejection
- Extracorporeal Photopheresis
-
Barcelona, Please Select, SpainDeparment of Nephology and Kidney Transplant
Mar 15, 2022
Rejection Diagnosis in Kidney Transplants Patients
Completed
- Kidney Transplantation
- +2 more
- Kidney transplantation
-
Paris, FranceHopital Saint-Louis
Feb 9, 2022
Acute Antibody-Mediated Rejection (AMR) Trial in Worldwide (Cinryze®, Placebo)
Terminated
- Acute Antibody-Mediated Rejection (AMR)
- Cinryze®
- Placebo
-
Los Angeles, California
- +46 more
Jul 9, 2020
Torque Teno Virus: A Biomarker of Immunosuppression
Recruiting
- Renal Transplant Rejection
- +3 more
- None Observational study
-
London, United KingdomRoyal London Hospital
Feb 23, 2023
HIV, Organ Transplantation, Lymphoma, Non-Hodgkin Trial in Melbourne (Pfizer Bivalent COVID-19 Vaccine, Moderna Bivalent mRNA
Recruiting
- HIV
- +5 more
- Pfizer Bivalent COVID-19 Vaccine
- Moderna Bivalent mRNA vaccine
-
Melbourne, Victoria, AustraliaAlfred Health
Jan 31, 2023
Allosensitization, Kidney Transplant Rejection, Antibody-mediated Rejection Trial in Créteil (Daratumumab dose escalation,
Recruiting
- Allosensitization
- +2 more
- Daratumumab dose escalation
- Daratumumab full dose
-
Créteil, FranceHenri Mondor
May 19, 2020
Trifecta-Kidney cfDNA-MMDx Study
Recruiting
- Kidney Transplant Rejection
- MMDx
- +2 more
-
Tampa, Florida
- +30 more
Oct 12, 2022
Microarrays in Lung Transplantation
Recruiting
- Lung Transplant Rejection
- Lung transplant biopsy bites.
-
Baltimore, Maryland
- +9 more
Oct 17, 2022
Trifecta-Heart cfDNA-MMDx Study
Recruiting
- Heart Transplant Rejection
- MMDx diagnostic test
- +2 more
-
Los Angeles, California
- +9 more
Aug 2, 2022
Predict Risk of Kidney Transplant Rejection
Recruiting
- Kidney Transplant Rejection
-
Chicago, Illinois
- +14 more
Sep 9, 2022